-
41دورية أكاديمية
المساهمون: Mijeong Son, Yukyung Kim, Donghwan Lee, Hyerang Roh, Hankil Son, Jinju Guk, Seong Bok Jang, Su Youn Nam, Kyungsoo Park, Kim, Yu Kyung, Roh, Hye Rang, Park, Kyung Soo, Son, Mi Jeong, Son, Han kil, Lee, Dong Hwan
مصطلحات موضوعية: Administration, Oral, Adult, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Antihypertensive Agents/pharmacokinetics, Area Under Curve, Asian Continental Ancestry Group, Benzimidazoles/administration & dosage, Benzimidazoles/adverse effects, Benzimidazoles/pharmacokinetics, Benzoates/administration & dosage, Benzoates/adverse effects, Benzoates/pharmacokinetics, Cough/chemically induced, Cross-Over Studies, Drug Interactions, Drug Therapy, Combination/adverse effects, Healthy Volunteers, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics, Male, Republic of Korea, Rosuvastatin Calcium/administration & dosage, Rosuvastatin Calcium/adverse effects, Rosuvastatin Calcium/pharmacokinetics, Young Adult
وصف الملف: 1147~1158
العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2014-01723; https://ir.ymlib.yonsei.ac.kr/handle/22282913/99643Test; http://www.sciencedirect.com/science/article/pii/S014929181400366XTest; T201402947; CLINICAL THERAPEUTICS, Vol.36(8) : 1147-1158, 2014
الإتاحة: https://doi.org/10.1016/j.clinthera.2014.06.007Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/99643Test
http://www.sciencedirect.com/science/article/pii/S014929181400366XTest -
42دورية أكاديمية
المساهمون: Hyerang Roh, Hankil Son, Donghwan Lee, HeeChul Chang, Chohee Yun, Kyungsoo Park, Roh, Hye Rang, Park, Kyung Soo, Son, Han kil, Lee, Dong Hwan
مصطلحات موضوعية: Administration, Oral, Adult, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Antihypertensive Agents/pharmacokinetics, Area Under Curve, Asian Continental Ancestry Group, Cross-Over Studies, Drug Interactions, Drug Therapy, Combination/adverse effects, Healthy Volunteers, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics, Imidazoles/administration & dosage, Imidazoles/adverse effects, Imidazoles/pharmacokinetics, Male, Middle Aged, Republic of Korea, Rosuvastatin Calcium/administration & dosage, Rosuvastatin Calcium/adverse effects, Rosuvastatin Calcium/pharmacokinetics, Tetrazoles/administration & dosage, Tetrazoles/adverse effects, Tetrazoles/pharmacokinetics, Young Adult
وصف الملف: 1159~1170
العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2014-01724; https://ir.ymlib.yonsei.ac.kr/handle/22282913/99644Test; http://www.sciencedirect.com/science/article/pii/S0149291814003865Test; T201402948; CLINICAL THERAPEUTICS, Vol.36(8) : 1159-1170, 2014
الإتاحة: https://doi.org/10.1016/j.clinthera.2014.06.022Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/99644Test
http://www.sciencedirect.com/science/article/pii/S0149291814003865Test -
43دورية أكاديمية
المساهمون: Jong Chan Youn, Sang Hyun Ihm, Jang Ho Bae, Seong Mi Park, Dong Woon Jeon, Byung Chun Jung, Tae Ho Park, Nae Hee Lee, Jong Min Song, Young Won Yoon, Eun Seok Shin, Ki Chul Sung, In Hyun Jung, Wook Bum Pyun, Seung Jae Joo, Woo Jung Park, Jin Ho Shin, Seok Min Kang, Kang, Seok Min, Yoon, Young Won, Youn, Jong Chan
مصطلحات موضوعية: Adult, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Double-Blind Method, Female, Humans, Hypertension/drug therapy, Hypertension/physiopathology, Male, Middle Aged, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Tetrazoles/adverse effects, Tetrazoles/therapeutic use, Treatment Outcome, Valsartan/adverse effects, Valsartan/therapeutic use, fimasartan, hypertension, placebo, valsartan
وصف الملف: 1412~1421
العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2014-03010; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test; http://www.sciencedirect.com/science/article/pii/S0149291814004391Test; T201405549; CLINICAL THERAPEUTICS, Vol.36(10) : 1412-1421, 2014
الإتاحة: https://doi.org/10.1016/j.clinthera.2014.07.004Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test
http://www.sciencedirect.com/science/article/pii/S0149291814004391Test -
44تقرير
المؤلفون: Eliasson, E, Böttiger, Y
المصدر: Läkartidningen. 101(35):2657
-
45تقرير
المؤلفون: Lindh, J, Böttiger, Y
المصدر: Läkartidningen. 101(14):1305
-
46تقرير
المؤلفون: Wurgler Hansen, K, Gregersen, C, Lenk-Hansen, L
المصدر: Ugeskrift for Laeger. 166(43):3828
-
47تقرير
المؤلفون: Ringholm Nielsen, L
المصدر: Ugeskrift for Laeger. 165(13):1368
-
48تقرير
المؤلفون: Lindhardt Olesen, A, Tollund, C, Söndergaard, I, Stöm, J J
المصدر: Ugeskrift for Laeger. 165(10):1041
-
49تقرير
المؤلفون: Valhovd, M, Kildahl-Andersen, O
المصدر: Tidsskrift for Den Norske Laegeforening. 123(9):1202
-
50تقرير
المؤلفون: Svarstad, E, Hultström, D, Jensen, D, Jenssen, G, Gravendeel, J, Iversen, B M
المصدر: Tidsskrift for Den Norske Laegeforening. 121(15):1784